Please login to the form below

Not currently logged in
Email:
Password:

mouth cancer

This page shows the latest mouth cancer news and features for those working in and with pharma, biotech and healthcare.

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata

on a number of key cancer drugs, with winners and losers across the board. ... NICE also found issue over a lack of separate clinical evidence for people whose cancer started outside the mouth, and incomplete information regarding Keytruda’s clinical

Latest news

  • NICE set to reject Merck’s Erbitux for head and neck cancer NICE set to reject Merck’s Erbitux for head and neck cancer

    Merck has since provided further evidence for Erbitux to assist this appraisal process, reducing the indication to patients with mouth cancer alone as well as proposing an additional, undisclosed discount. ... However, the committee said that the new

  • PR and Med Ed news in brief

    Mouth Cancer Awareness Week 2004 was the most successful mouth cancer campaign ever said the British Dental Health Foundation.

  • Ethnic Minority Cancer Awareness Week

    Sir Trevor McDonald is backing a campaign to raise levels of awareness about the affects of cancer on Black and Minority Ethnic communities. ... of mouth cancer and Bangladeshi and Chinese communities having a higher incidence of liver cancer.

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....
Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....